Study of M5049 in DM and PM Participants (NEPTUNIA)
Conditions:   Dermatomyositis;   Polymyositis Interventions:   Drug: M5049 high dose;   Drug: Placebo Sponsors:   EMD Serono Research & Development Institute, Inc.;   Merck KGaA, Darmstadt, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2022 Category: Research Source Type: clinical trials

Plexin D1 as a Potential Biomarker inPM/DM
Conditions:   Polymyositis;   Dermatomyositis Intervention:   Diagnostic Test: plexinD1 Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2022 Category: Research Source Type: clinical trials